{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:32:20Z","timestamp":1774675940089,"version":"3.50.1"},"reference-count":22,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,12,3]]},"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>We describe a case of delayed onset, acute demyelinating neuropathy secondary to novel SARS-CoV-2 infection. A previously healthy 46-year-old man presented with bilateral leg pain and loss of sensation in his feet 53 days after having COVID-19 pneumonitis. He developed painful sensory symptoms followed by a rapidly progressive lower motor neuron weakness involving all limbs, face and respiratory muscles, needing ventilatory support. In keeping with a diagnosis of Guillain-Barr\u00e9 syndrome, cerebrospinal fluid examination showed albuminocytologic dissociation and nerve conduction studies supported the diagnosis of an acute inflammatory demyelinating polyradiculoneuropathy. The delayed neurological dysfunction seen in our patient following SARS-CoV-2 infection may indicate a novel mechanism of disease that is part of the emerging \u2018long COVID-19 syndrome\u2019.<\/jats:p>","DOI":"10.1136\/bcr-2020-240178","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T12:34:02Z","timestamp":1610973242000},"page":"e240178","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":51,"title":["Late onset of Guillain-Barr\u00e9 syndrome following SARS-CoV-2 infection: part of \u2018long COVID-19 syndrome\u2019?"],"prefix":"10.1136","volume":"14","author":[{"given":"Mina M","family":"Raahimi","sequence":"first","affiliation":[{"name":"Critical Care, Portsmouth Hospitals University NHS Trust, Portsmouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Kane","sequence":"additional","affiliation":[{"name":"Acute Medical Unit, Portsmouth Hospitals University NHS Trust, Portsmouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher EG","family":"Moore","sequence":"additional","affiliation":[{"name":"Neurophysiology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad W","family":"Alareed","sequence":"additional","affiliation":[{"name":"Neurophysiology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"2025082803175360000_14.1.e240178.1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","article-title":"Lifting the mask on neurological manifestations of COVID-19","volume":"16","author":"Pezzini","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"2025082803175360000_14.1.e240178.2","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2020.20387","article-title":"Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult","volume":"150","author":"Othenin-Girard","year":"2020","journal-title":"Swiss Med Wkly"},{"key":"2025082803175360000_14.1.e240178.3","doi-asserted-by":"crossref","unstructured":"Needham E , Newcombe V , Michell A . Mononeuritis multiplex: an unexpectedly common feature of severe COVID-19. medRxiv 2020.doi:10.1101\/2020.07.19.20149898","DOI":"10.1101\/2020.07.19.20149898"},{"key":"2025082803175360000_14.1.e240178.4","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jinf.2020.08.029","article-title":"Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19","volume":"81","author":"Garrigues","year":"2020","journal-title":"J Infect"},{"key":"2025082803175360000_14.1.e240178.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12603"},{"key":"2025082803175360000_14.1.e240178.6","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6930e1"},{"key":"2025082803175360000_14.1.e240178.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)12308-X"},{"key":"2025082803175360000_14.1.e240178.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261706"},{"key":"2025082803175360000_14.1.e240178.9","unstructured":"Horby P , Landary M . Recovery trial, 2020. Available: https:\/\/www.recoverytrial.net\/"},{"key":"2025082803175360000_14.1.e240178.10","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270707"},{"key":"2025082803175360000_14.1.e240178.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1"},{"key":"2025082803175360000_14.1.e240178.12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jns.12419","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: a systematic review and individual participant data meta-analysis","volume":"25","author":"Hasan","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"2025082803175360000_14.1.e240178.13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm004"},{"key":"2025082803175360000_14.1.e240178.14","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.121"},{"key":"2025082803175360000_14.1.e240178.15","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2017.13.3.227"},{"key":"2025082803175360000_14.1.e240178.16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324491"},{"key":"2025082803175360000_14.1.e240178.17","doi-asserted-by":"crossref","unstructured":"Abu-Rumeileh S , Abdelhak A , Foschi M . Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol 2020:1\u201338.","DOI":"10.1007\/s00415-020-10124-x"},{"key":"2025082803175360000_14.1.e240178.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"2025082803175360000_14.1.e240178.19","article-title":"Association between male sex and outcomes of Coronavirus Disease 2019 (Covid-19) - a Danish nationwide, register-based study","author":"Kragholm","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025082803175360000_14.1.e240178.20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.12688\/wellcomeopenres.15987.2","article-title":"COVID-19 and Guillain-Barre syndrome: a systematic review of case reports","volume":"5","author":"Carrillo-Larco","year":"2020","journal-title":"Wellcome Open Res"},{"key":"2025082803175360000_14.1.e240178.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30109-5"},{"key":"2025082803175360000_14.1.e240178.22","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-240178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:18:02Z","timestamp":1756376282000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-240178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,18]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/bcr-2020-240178"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-240178","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}